Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
3.650
+0.233 (6.81%)
Apr 25, 2025, 12:34 PM EDT - Market open

Kazia Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2015 - 2019
Market Capitalization
47265812832
Upgrade
Market Cap Growth
-74.25%-74.25%-54.61%-54.40%298.54%98.02%
Upgrade
Enterprise Value
35244711328
Upgrade
Last Close Price
3.4211.4358.00210.00493.00169.50
Upgrade
PS Ratio
1.094.1139743.178458.3411.2347.01
Upgrade
PB Ratio
-0.57-1.023.304.634.503.29
Upgrade
P/TBV Ratio
----10.7627.08
Upgrade
EV/Sales Ratio
1.902.8035823.576855.409.9140.38
Upgrade
Debt / Equity Ratio
-0.06-0.060.150.10--
Upgrade
Asset Turnover
0.100.10000.370.05
Upgrade
Quick Ratio
0.070.070.711.103.321.97
Upgrade
Current Ratio
0.240.241.421.403.532.10
Upgrade
Return on Equity (ROE)
-2634.33%-2634.33%-134.97%-89.14%-32.41%-88.05%
Upgrade
Return on Assets (ROA)
-71.63%-71.63%-47.18%-33.76%-9.83%-34.45%
Upgrade
Return on Capital (ROIC)
-797.17%-797.17%-88.87%-54.74%-15.34%-53.82%
Upgrade
Earnings Yield
-467.68%-262.32%-51.49%-29.57%-4.94%-26.84%
Upgrade
FCF Yield
-159.95%-93.86%-38.14%-26.91%-5.34%-18.97%
Upgrade
Buyback Yield / Dilution
-43.08%-43.08%-39.12%-12.57%-61.08%-27.04%
Upgrade
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q